Clinical trial
Skin Sensitization Test (Modified Draize-95 Test) to Support a Low Dermatitis Potential Claim
NCT03886987 is registered in ClinicalTrials.gov with Central Medicare Sdn. Bhd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Skin Sensitization Test (Modified Draize-95 Test) to Support a Low Dermatitis Potential Claim
- Lead sponsor
- Central Medicare Sdn. Bhd.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 2, 2018
- Completion date
- June 8, 2018
- Enrollment
- 245 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
skin sensitisation